Skip to main content
Caplight Logo









Carina Biotech

Carina Biotech

Private
Mawson LakesHealthcare & Life Scienceshttps://www.carinabiotech.com/

Last Round

Early Funding

Apr 15, 2025

Total Funding Raised

$14.58M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Carina Biotech is a biotechnology company that researches and develops chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

CAR-T therapycell therapyimmuno-oncologysolid tumor therapycolorectal cancercancer stem cellsimmunotherapyLGR5-targeted therapyclinical-stage biotechpersonalized cell therapychemokine receptor platformCAR-T manufacturingdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Carina Biotech Comparables

Compare Carina Biotech with similar companies based on industry and business-model similarity.

Carina Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Invectys
80%
AffyImmune Therapeutics
78%
A2 Biotherapeutics
77%

Carina Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingApr 15, 2025
Series AAug 15, 2022
Early FundingSep 1, 2021
GrantApr 23, 2020

Carina Biotech Investors

Notable investors and investment history

Carina Biotech investors
InvestorRounds
Minderoo FoundationSeries A, Early Funding
University of AdelaideSeries A
TenmileSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 34% MoM, reaching 3.2K.

  • Dec 22, 2025

    Grew 19% QoQ, from 16 to 19 employees.

Carina Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Carina Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Carina Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersMawson Lakes
Employee Range16
Year Founded2016
Last FundingApr 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?